274 related articles for article (PubMed ID: 29461148)
1. [Not Available].
Viardot A
Ther Umsch; 2017; 74(8):423-431. PubMed ID: 29461148
[No Abstract] [Full Text] [Related]
2. The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitus.
Charokopou M; McEwan P; Lister S; Callan L; Bergenheim K; Tolley K; Postema R; Townsend R; Roudaut M
Diabet Med; 2015 Jul; 32(7):890-8. PubMed ID: 25817050
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of dapagliflozin (Forxiga®) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countries.
Sabale U; Ekman M; Granström O; Bergenheim K; McEwan P
Prim Care Diabetes; 2015 Feb; 9(1):39-47. PubMed ID: 24840612
[TBL] [Abstract][Full Text] [Related]
4. Is gliclazide a sulfonylurea with difference? A review in 2016.
Singh AK; Singh R
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):839-51. PubMed ID: 26924475
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource use and associated costs of hypoglycemia in patients with type 2 diabetes prescribed sulfonylureas.
Alemayehu B; Liu J; Rajpathak S; Engel SS
J Diabetes Complications; 2017 Nov; 31(11):1620-1623. PubMed ID: 28844830
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of the efficacy and hypoglycemic safety of gliclazide versus other insulinotropic agents.
Chan SP; Colagiuri S
Diabetes Res Clin Pract; 2015 Oct; 110(1):75-81. PubMed ID: 26361859
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of saxagliptin vs glimepiride as a second-line therapy added to metformin in Type 2 diabetes in China.
Gu S; Deng J; Shi L; Mu Y; Dong H
J Med Econ; 2015; 18(10):808-20. PubMed ID: 25950193
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia in Frail Elderly Patients With Type 2 Diabetes Mellitus Treated With Sulfonylurea.
van Dijk P; Bouma A; Landman GW; Groenier KH; Bilo H; Kleefstra N; van Hateren KJ
J Diabetes Sci Technol; 2017 Mar; 11(2):438-439. PubMed ID: 27625346
[No Abstract] [Full Text] [Related]
9. Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
Vos RC; Rutten GEHM
JAMA; 2017 Oct; 318(15):1489-1490. PubMed ID: 29049639
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy, secondary failure rate, and complications of sulfonylureas.
Harrower AD
J Diabetes Complications; 1994; 8(4):201-3. PubMed ID: 7833494
[TBL] [Abstract][Full Text] [Related]
11. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
Scheen AJ
Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
[TBL] [Abstract][Full Text] [Related]
12. [Hardly any hypoglycemias, constant weight--and still cost effective].
MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
[No Abstract] [Full Text] [Related]
13. Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada.
Boulin M; Diaby V; Tannenbaum C
PLoS One; 2016; 11(9):e0162951. PubMed ID: 27648831
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of glimepiride].
Kaneko T; Sakamoto N
Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
[No Abstract] [Full Text] [Related]
16. [Safety is the issue again].
Overbeck P
MMW Fortschr Med; 2013 Oct; 155(17):26. PubMed ID: 24340377
[No Abstract] [Full Text] [Related]
17. Clinical evaluation of glimepiride (HOE490) in NIDDM, including a double blind comparative study versus gliclazide.
Tsumura K
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S147-9. PubMed ID: 8529507
[TBL] [Abstract][Full Text] [Related]
18. [Hypoglycemia].
Gupta PS; Green AN; Chowdhury TA
Praxis (Bern 1994); 2011 Oct; 100(21):1303-5. PubMed ID: 22012756
[No Abstract] [Full Text] [Related]
19. Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications.
Vaughan EM; Rueda JJ; Samson SL; Hyman DJ
Curr Diabetes Rev; 2020; 16(8):851-858. PubMed ID: 32026779
[TBL] [Abstract][Full Text] [Related]
20. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
Crawford BA; Perera C
Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
